The CDC reports about 100,000 people in the United States are affected by Sickle cell disease, and more than 90% are non-Black or African American. One local organization is aiming to shed light on ...

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

Years ago, when Christ’s parents discovered through a blood test that they carried the sickle cell trait, they had him tested and it revealed that he did indeed have the disease. It was shortly after ...

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

By taking an interdisciplinary approach to science class, teachers are able to deepen understanding of content—and sharpen ...

The following is a summary of “Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre study,” published in the February 2025 ...

More than 100 million people globally have had a stroke, but there are ways to reduce your risk and spot the signs of stroke ...

"Turkana Food Inc. Kenilworth, NJ is recalling 858 cases OF Aleppo Tahini Sesame Paste because it has the potential to be ...

Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, ...

Regeneron, San Diego-based biotech company Illumina and 17 health systems invested in the $320 million round. Regeneron ...

On CRSP's fourth-quarter 2024 earnings call, investors' focus will likely be on the sales figure of Casgevy, its first marketed product.

One in six deaths from cardiovascular disease in the United States is due to stroke, and over 100 million people worldwide ...